Thus, these in vitro studies indicating hypo-Hippo signaling may better reflect the pathological mechanisms that occur at a later stage of AD pathogenesis, when Aβ levels are higher, suggesting that under higher Aβ burden inhibiting Hippo signaling and promoting YAP nuclear translocation could be detrimental. The gene discussed is YAP1; the disease is Alzheimer disease.